Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition.

Author: DuanErick H, GarrisonKeith E, JonesR Brad, NixonDouglas F, OstrowskiMario A, WongJessica C

Paper Details 
Original Abstract of the Article :
Intact LINE-1 elements are the only retrotransposons encoded by the human genome known to be capable of autonomous replication. Numerous cases of genetic disease have been traced to gene disruptions caused by LINE-1 retrotransposition events in germ-line cells. In addition, genomic instability resul...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212136/

データ提供:米国国立医学図書館(NLM)

LINE-1 Retrotransposons: A Double-Edged Sword in Human Genetics

LINE-1 elements are a type of retrotransposon, which are genetic sequences that can move around within the genome. This study investigates the effects of nucleoside analogue reverse transcriptase inhibitors (NARTIs), commonly used to treat HIV infection, on the activity of LINE-1 retrotransposons. The researchers found that NARTIs can differentially inhibit the activity of LINE-1 retrotransposons. This finding is significant because LINE-1 retrotransposons have been implicated in various genetic diseases, including cancer. The research provides valuable insights into the potential interactions between antiretroviral medications and human retrotransposons.

NARTIs: A Potential Impact on LINE-1 Retrotransposons

The study's findings highlight the potential impact of NARTIs on the activity of LINE-1 retrotransposons. This suggests that NARTIs could potentially have broader implications for human health beyond their role in HIV treatment.

Navigating the Complexities of the Genome

This research underscores the complex interplay between genetic elements and pharmaceutical interventions. It's essential to be aware of the potential interactions between medications and the genome, as these interactions can have significant implications for human health.

Dr. Camel's Conclusion

This study offers a fascinating glimpse into the complex world of retrotransposons and their potential impact on human health. The research highlights the need for further investigation into the interactions between medications and the genome, ensuring patient safety and optimizing treatment outcomes.

Date :
  1. Date Completed 2008-07-15
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

18253495

DOI: Digital Object Identifier

PMC2212136

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.